D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$315M |
| 2 |
Exxon Mobil
XOM
|
+$312M |
| 3 |
Verizon
VZ
|
+$289M |
| 4 |
Procter & Gamble
PG
|
+$288M |
| 5 |
Pfizer
PFE
|
+$272M |
Top Sells
| 1 |
Tesla
TSLA
|
+$619M |
| 2 |
Biogen
BIIB
|
+$369M |
| 3 |
Amazon
AMZN
|
+$341M |
| 4 |
Netflix
NFLX
|
+$309M |
| 5 |
Emerson Electric
EMR
|
+$306M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Healthcare | 14.5% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 9.56% |
| 5 | Communication Services | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
FormFactor
FORM
$2.35B
| $2.96M | ﹤0.01% |
147,158
+136,116
| +1,233% | +$2.74M |
|
|
DRNA
1252
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.96M | ﹤0.01% |
160,849
+41,579
| +35% | +$764K |
|
1253
Chefs' Warehouse
CHEF
$2.71B
| $2.95M | ﹤0.01% |
+292,881
| New | +$2.95M |
|
1254
New Oriental
EDU
$8.73B
| $2.95M | ﹤0.01% |
27,225
+21,789
| +401% | +$2.36M |
|
1255
Essex Property Trust
ESS
$17.2B
| $2.94M | ﹤0.01% |
13,362
-12,869
| -49% | -$2.83M |
|
1256
Interface
TILE
$1.66B
| $2.94M | ﹤0.01% |
389,074
-111,989
| -22% | -$847K |
|
1257
Valmont Industries
VMI
$7.49B
| $2.94M | ﹤0.01% |
27,753
-11,957
| -30% | -$1.27M |
|
1258
V2X
VVX
$1.7B
| $2.94M | ﹤0.01% |
71,004
-56,694
| -44% | -$2.35M |
|
|
GPMT
1259
Granite Point Mortgage Trust
GPMT
$142M
| $2.93M | ﹤0.01% |
576,749
+547,477
| +1,870% | +$2.78M |
|
1260
BILL Holdings
BILL
$5.21B
| $2.92M | ﹤0.01% |
+85,300
| New | +$2.92M |
|
1261
Renasant Corp
RNST
$3.7B
| $2.89M | ﹤0.01% |
132,510
+55,426
| +72% | +$1.21M |
|
1262
Rocket Pharmaceuticals
RCKT
$342M
| $2.89M | ﹤0.01% |
207,403
+188,976
| +1,026% | +$2.64M |
|
1263
Carlyle Secured Lending
CGBD
$999M
| $2.89M | ﹤0.01% |
552,692
-7,522
| -1% | -$39.3K |
|
|
FL
1264
DELISTED
Foot Locker
FL
| $2.88M | ﹤0.01% |
130,558
-110,587
| -46% | -$2.44M |
|
1265
Arlo Technologies
ARLO
$1.8B
| $2.87M | ﹤0.01% |
1,182,292
+358,111
| +43% | +$870K |
|
|
ITCI
1266
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.87M | ﹤0.01% |
186,447
-44,966
| -19% | -$691K |
|
1267
Blue Owl Capital
OBDC
$7.25B
| $2.86M | ﹤0.01% |
248,055
+206,676
| +499% | +$2.39M |
|
1268
Plexus
PLXS
$3.72B
| $2.85M | ﹤0.01% |
52,285
-4,680
| -8% | -$255K |
|
|
BNFT
1269
DELISTED
Benefitfocus, Inc.
BNFT
| $2.85M | ﹤0.01% |
319,613
+130,517
| +69% | +$1.16M |
|
1270
Deluxe
DLX
$882M
| $2.84M | ﹤0.01% |
109,547
-197,080
| -64% | -$5.11M |
|
|
ILPT
1271
Industrial Logistics Properties Trust
ILPT
$420M
| $2.84M | ﹤0.01% |
161,731
-71,191
| -31% | -$1.25M |
|
|
ALEX
1272
Alexander & Baldwin
ALEX
$1.35B
| $2.83M | ﹤0.01% |
252,617
+32,205
| +15% | +$361K |
|
1273
Revvity
RVTY
$9.66B
| $2.8M | ﹤0.01% |
37,177
-34,487
| -48% | -$2.6M |
|
1274
Southwest Gas
SWX
$5.69B
| $2.79M | ﹤0.01% |
40,169
-25,780
| -39% | -$1.79M |
|
|
ODT
1275
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $2.78M | ﹤0.01% |
100,707
-11,290
| -10% | -$312K |
|